Acute Cholecystitis
Persistent cystic-duct obstruction inflames the gallbladder rather than causing transient biliary colic: assess for sepsis and common-bile-duct disease, give supportive and antimicrobial treatment when indicated, and arrange early source control.
Definition
Acute cholecystitis is acute inflammation of the gallbladder, most often caused by a stone or sludge obstructing the cystic duct. Acalculous cholecystitis occurs without stones, particularly in critically ill patients, and can be equally serious.
Epidemiology
Gallstones are common in adults and many remain asymptomatic. Acute cholecystitis is a frequent upper-GI surgical admission, usually after persistent cystic-duct obstruction, while acalculous disease is more associated with critical illness, postoperative states and major systemic stress.
Pathophysiology
Persistent cystic-duct obstruction traps bile and raises gallbladder pressure. Wall oedema, inflammation and reduced perfusion develop, with secondary infection in some patients. Continued inflammation can cause empyema, gangrene, perforation or abscess. Acalculous disease results from stasis and ischaemia without a gallstone.
First principles
Persistent obstruction makes the gallbladder inflamed
A stone or sludge that remains impacted at the cystic duct or gallbladder neck prevents drainage. Distension, wall oedema and local inflammation follow; secondary infection may occur. This produces constant right-upper-quadrant pain and systemic features rather than the short-lived, self-limiting pain of biliary colic.1,2
The cystic duct and common bile duct are different pathways
Acute cholecystitis is primarily a gallbladder and cystic-duct problem. Jaundice, a cholestatic liver-test pattern or a dilated common bile duct raises concern for a second problem such as a common-bile-duct stone, which needs MRCP or EUS and a bile-duct-clearance pathway rather than assuming uncomplicated cholecystitis.1
Ultrasound and liver tests guide the next branch
NICE recommends liver-function tests and ultrasound for suspected gallstone disease. Ultrasound assesses gallstones and gallbladder inflammation, while liver tests help identify patients who need further common-bile-duct imaging. No single sign, laboratory result or ultrasound feature should replace the overall clinical assessment.1
Source control prevents recurrent and progressive disease
Supportive treatment and antibiotics may control the acute inflammatory or infective episode, but they do not remove the gallbladder source. NICE recommends early laparoscopic cholecystectomy within one week of diagnosis; drainage is reserved for selected patients in whom surgery is contraindicated or not an option.1,2,3
Presentation
Persistent right-upper-quadrant or epigastric pain with tenderness or a positive Murphy sign, nausea or vomiting and systemic inflammation. Jaundice, shock, peritonism or rapid deterioration suggests duct obstruction, sepsis or a complication rather than uncomplicated cholecystitis.1,2
Cardinal features
- Constant right-upper-quadrant or epigastric pain
- Right-upper-quadrant tenderness or a positive Murphy sign
- Fever, tachycardia or other systemic inflammatory features
- Nausea, vomiting and anorexia
- Gallstones or gallbladder inflammatory changes on ultrasound
- Raised inflammatory markers, with liver tests helping identify duct involvement
Red flags
- Hypotension, confusion, raised lactate or organ dysfunction suggesting sepsis
- Generalised peritonism, severe local tenderness or sudden deterioration suggesting gangrene or perforation
- Jaundice, a markedly cholestatic liver-test pattern or a dilated common bile duct
- Persistent fever or pain despite initial treatment, suggesting empyema, gangrene, abscess or uncontrolled source
- Critically ill, postoperative or immunocompromised patient with possible acalculous cholecystitis
- Gas in the gallbladder wall or lumen, especially in a patient with diabetes, suggesting emphysematous disease
Investigations
Liver-function tests and inflammatory blood tests
Check liver tests and inflammatory markers alongside FBC, renal function, electrolytes, glucose and lactate when clinically indicated. The pattern helps separate isolated gallbladder inflammation from common-bile-duct obstruction and identifies systemic illness requiring escalation.
Expected finding: Inflammatory markers may be raised in acute cholecystitis. Normal or mildly abnormal liver tests support an isolated gallbladder process; marked cholestatic abnormality or jaundice raises concern for common-bile-duct disease.
1,4Transabdominal ultrasound
Use ultrasound first line to identify gallstones and signs of acute gallbladder pathology and to assess the bile duct. Interpret gallbladder wall, distension, pericholecystic fluid, an impacted neck stone and sonographic tenderness together with the clinical picture.
Expected finding: Gallstones with gallbladder distension, wall inflammation, pericholecystic fluid or sonographic Murphy sign may support acute cholecystitis. A dilated common bile duct or visible duct stone changes the pathway.
1,2MRCP or endoscopic ultrasound for suspected common-bile-duct stone
If ultrasound has not detected a duct stone but the bile duct is dilated or liver tests are abnormal, consider MRCP. If MRCP is non-diagnostic, consider EUS. Do not use an isolated gallbladder diagnosis to ignore jaundice or cholestasis.
Expected finding: A duct stone, obstruction or alternative biliary lesion may be demonstrated. Positive findings require bile-duct clearance planning, usually with ERCP before or at the time of cholecystectomy or surgical clearance.
1Sepsis and operative-risk assessment
Use ABCDE, observations, urine output, lactate and organ-function assessment when the patient is systemically unwell. Obtain ECG, group and save/crossmatch and other pre-operative tests according to the clinical and anaesthetic risk, without delaying source control unnecessarily.
Expected finding: Sepsis, shock, renal dysfunction, coagulopathy or severe comorbidity determines escalation, antibiotic route, anaesthetic planning and whether drainage or surgery is currently safe.
4,1Management
| Step | Detail | Source |
|---|---|---|
| Stabilise, relieve symptoms and assess for sepsis | Use ABCDE, give appropriate IV fluids for hypovolaemia, analgesia and antiemetic treatment, and keep the patient nil by mouth while surgical assessment is underway. Monitor observations, urine output and organ function. Use current BNF and local protocols for drug choice, dose, renal adjustment and contraindications.1,2,4,5,6 | NICE CG188, NICE HTG617 and current BNF monographs |
| Give antimicrobial treatment when infection or sepsis is suspected | Start empirical antimicrobial treatment when clinically indicated by acute infection, sepsis, complicated disease or the local surgical pathway. Choose the regimen, route, renal adjustment and duration from the current local antimicrobial policy and BNF; review after source control, microbiology and clinical response rather than continuing broad treatment automatically.2,4,7,8,9 | NICE HTG617, NICE NG253 and current BNF antimicrobial monographs |
| Arrange early laparoscopic cholecystectomy | Offer laparoscopic cholecystectomy within one week of diagnosis. Early surgery provides definitive source control and avoids the recurrent attacks and complications associated with waiting for the acute episode to settle. Involve the senior upper-GI surgical and anaesthetic teams early when disease is severe or the operative risk is high.1,10 | NICE CG188 recommendation 1.2.4 and NICE QS104 |
| Clear a suspected common-bile-duct stone through the correct pathway | If jaundice, cholestatic liver tests, a dilated duct or MRCP/EUS evidence suggests common-bile-duct stones, plan bile-duct clearance surgically at cholecystectomy or with ERCP before or at surgery. If ERCP cannot clear the duct, biliary stenting is a temporary drainage measure until definitive endoscopic or surgical clearance.1 | NICE CG188 recommendations 1.3.1 to 1.3.4 |
| Use gallbladder drainage only when surgery is unsafe or unavailable | Offer percutaneous cholecystostomy for gallbladder empyema when surgery is contraindicated at presentation and conservative management is unsuccessful. Reconsider cholecystectomy once the patient is well enough. Endoscopic ultrasound-guided gallbladder drainage can be used when surgery is not an option only in a specialist service with appropriate governance, consent and audit.1,2,3 | NICE CG188 recommendations 1.2.5 to 1.2.6 and NICE HTG683 |
| Escalate complications and provide safe follow-up | Generalised peritonitis, gangrene, perforation, abscess, emphysematous disease, uncontrolled sepsis or clinical deterioration needs urgent senior surgical and critical-care review. After recovery, explain wound and bile-duct follow-up, review histology and ensure symptomatic gallstones are not left untreated without a documented plan.1,4,2 | NICE CG188, NICE NG253 and NICE HTG617 |
Illustrations
Differentials
Biliary colic
Transient postprandial pain without persistent systemic inflammation or inflammatory gallbladder changes.
Ascending cholangitis
Systemic infection with jaundice or cholestatic obstruction from the common bile duct; requires urgent biliary drainage assessment.
Gallstone pancreatitis
Predominantly epigastric pain radiating to the back with compatible pancreatic enzyme and imaging findings.
Peptic ulcer disease or perforation
Epigastric pain, peritonism or free intraperitoneal gas rather than an isolated gallbladder process.
Right lower-lobe pneumonia or acute coronary syndrome
Referred upper-abdominal pain with respiratory, ECG or cardiac findings.
Liver abscess or hepatitis
Systemic illness or liver-test pattern and imaging findings that do not fit isolated cholecystitis.
Complications
- Gallbladder empyema
- Gangrene, perforation, abscess and biliary peritonitis
- Emphysematous cholecystitis
- Common-bile-duct obstruction and ascending cholangitis
- Cholecystoenteric fistula and gallstone ileus
- Recurrent biliary attacks and recurrent admissions
- Sepsis, organ dysfunction and death
Prognosis
Most suitable patients recover with supportive treatment, appropriate antimicrobial therapy and early laparoscopic cholecystectomy. Complicated, acalculous and septic disease carries higher risk, and prognosis depends on rapid recognition, resuscitation, biliary assessment and definitive source control.
Guidelines
- Gallstone disease: diagnosis and management (CG188) (NICE, 2014)
- Endoscopic ultrasound-guided gallbladder drainage when surgery is not an option (HTG683) (NICE, 2023)
References
- NICE CG188: Gallstone disease: diagnosis and management (CG188, current recommendations supported by 2018 surveillance)Published 29 Oct 2014 | Updated 31 Aug 2018
- NICE HTG617: Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis (Current treatments and procedure, published 9 March 2022)Published 9 Mar 2022
- NICE HTG683: Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis when surgery is not an option (Recommendations, published 22 June 2023)Published 22 Jun 2023
- NICE NG253: Suspected sepsis in people aged 16 or over: recognition, assessment and early management (Current sepsis recognition and management recommendations)Published 19 Nov 2025 | Updated 5 Dec 2025
- BNF: Paracetamol (BNF analgesic monograph)
- BNF: Morphine sulfate (BNF opioid analgesic monograph)
- BNF: Co-amoxiclav (BNF antimicrobial monograph)
- BNF: Metronidazole (BNF antimicrobial monograph)
- BNF: Ceftriaxone (BNF antimicrobial monograph)
- NICE QS104: Gallstone disease, quality statement 1 (Adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis)Published 3 Dec 2015
Evidence checked: 2026-08-03
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

